Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumour markers--magic or menace?

P Barker1, S Millroy

  • 1Royal Hospital Haslar, Gosport, Hants, PO12 2AA.

Journal of the Royal Naval Medical Service
|April 27, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal cortisol exposure impairs adrenal function but not glucose metabolism in adult sheep.

The Journal of endocrinology·2023
Same author

GDF15 linked to maternal risk of nausea and vomiting during pregnancy.

Nature·2023
Same author

Fetally-encoded GDF15 and maternal GDF15 sensitivity are major determinants of nausea and vomiting in human pregnancy.

bioRxiv : the preprint server for biology·2023
Same author

Age and the anaesthetist: considerations for the individual anaesthetist and workforce planning: Guidelines about the ageing anaesthetic workforce from the Association of Anaesthetists: Guidelines for the ageing anaesthetic workforce from the Association of Anaesthetists.

Anaesthesia·2022
Same author

Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK.

Anaesthesia·2020
Same author

Direct isotopic evidence of biogenic methane production and efflux from beneath a temperate glacier.

Scientific reports·2018
Same journal

Humidifier fever on a Type 42 destroyer.

Journal of the Royal Naval Medical Service·2018
Same journal

Humidifier fever on a Type 42 destroyer.

Journal of the Royal Naval Medical Service·2018
Same journal

Conditions of the external and middle ear: an overview of presentation, management and associated complications.

Journal of the Royal Naval Medical Service·2018
Same journal

Obstructive jaundice: a clinical review for the UK armed forces.

Journal of the Royal Naval Medical Service·2018
Same journal

Comparison of glycated haemoglobin and fasting blood glucose in the diagnosis of diabetes mellitus and pre-diabetes in a cohort of obese patients.

Journal of the Royal Naval Medical Service·2018
Same journal

CrossFitter’s knee: patellofemoral chondral injury following high-intensity functional training.

Journal of the Royal Naval Medical Service·2018
See all related articles

Early detection of breast cancer metastasis using serum tumor markers may enable timely treatment. Further multi-center studies are needed to confirm if this approach is life-saving or adds unnecessary costs and confusion.

Area of Science:

  • Oncology
  • Medical Diagnostics

Background:

  • Current breast cancer follow-up relies on symptomatic detection, often after significant tumor burden.
  • Late detection via symptomatic basis and UICC criteria may lead to less effective treatment outcomes.
  • Serum tumor markers offer a potential method for earlier disease detection when tumor volume is low.

Purpose of the Study:

  • To evaluate the effectiveness of serum tumor marker estimation for early breast cancer metastasis detection.
  • To determine if early detection via tumor markers allows for more effective and timely therapeutic intervention.
  • To assess the clinical utility and cost-effectiveness of serum tumor markers in breast cancer follow-up.

Main Methods:

  • Utilizing serum tumor marker (STM) estimation for monitoring breast cancer patients.

Related Experiment Videos

  • Comparing STM-based detection with traditional symptomatic follow-up and UICC criteria.
  • Proposing a randomized multi-center study to validate findings.

    • Main Results:

    • Preliminary findings in a District General Hospital setting suggest STM estimation allows early treatment initiation.
    • STM monitoring may help in assessing the efficacy of ongoing cancer therapies.
    • The study highlights the need for robust evidence regarding the benefits and drawbacks of STM use.

    Conclusions:

    • Serum tumor markers show promise for early breast cancer metastasis detection and treatment monitoring.
    • A large-scale randomized multi-center study is crucial to establish the definitive role of STMs in breast cancer care.
    • The findings necessitate further investigation to determine if STMs are a sensible, life-saving tool or a costly, confusing addition to follow-up protocols.